Antibiotic Selection for Infected Skin Tear
For an infected skin tear in an adult without MRSA risk factors, start with a beta-lactam antibiotic targeting beta-hemolytic streptococci—specifically cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 5-10 days. 1, 2
Clinical Assessment Framework
First, determine if the infection is purulent (with drainage/exudate) or nonpurulent (no drainage, no abscess). This distinction drives antibiotic selection.
For Nonpurulent Infection (Most Skin Tears)
Since you specified no MRSA risk factors, the primary pathogens are beta-hemolytic streptococci (Group A Strep). 1, 3
Oral antibiotic options:
- Cephalexin 500 mg four times daily (preferred for convenience and tolerability) 2
- Dicloxacillin 500 mg four times daily (more targeted but less convenient dosing) 2
- Amoxicillin-clavulanate 875/125 mg twice daily (broader coverage) 2
For penicillin-allergic patients:
If Purulent Features Develop
If the skin tear shows purulent drainage without a drainable abscess, you must cover CA-MRSA empirically while awaiting cultures. 1, 3
Oral MRSA-active options:
- Clindamycin 300-450 mg four times daily (covers both streptococci and MRSA) 3, 5
- TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin 500 mg three times daily (combination needed for streptococcal coverage) 1, 3
- Doxycycline 100 mg twice daily PLUS amoxicillin 500 mg three times daily 1, 5
Duration of Therapy
5-10 days total, individualized to clinical response. 1, 3 Recent evidence supports shorter courses (5-7 days) when clinical improvement is evident. 6
Critical Decision Points
Add MRSA coverage if:
- Failure to respond to beta-lactam therapy within 48-72 hours 1
- Systemic toxicity present (fever, tachycardia, hypotension) 1
- Purulent drainage develops 1, 3
Consider hospitalization with IV antibiotics if:
- Rapid progression with surrounding cellulitis 3
- Signs of systemic illness (SIRS criteria) 2
- Immunosuppression or significant comorbidities 3
- Extremes of age 3
Common Pitfalls to Avoid
Do not empirically cover MRSA in simple nonpurulent skin tears without risk factors. The IDSA guidelines explicitly state that for nonpurulent cellulitis, empirical streptococcal coverage is recommended, and MRSA coverage should be reserved for treatment failures or systemic toxicity. 1, 3 Overuse of broad-spectrum antibiotics drives resistance.
Do not use TMP-SMX or doxycycline alone for nonpurulent infections—these lack reliable streptococcal coverage and require combination with a beta-lactam. 1, 3
Avoid rifampin as monotherapy or adjunctive therapy—it provides no benefit and promotes resistance. 1, 3
Wound Care Essentials
Beyond antibiotics, proper wound management is critical:
- Keep the wound covered with clean, dry dressings 1
- Regular hand hygiene with soap and water or alcohol-based sanitizer 3, 1
- If drainage persists, consider culture to guide therapy 3, 1
When Cultures Are Indicated
Obtain wound cultures if: 3, 1
- Severe local infection or systemic illness
- Inadequate response to initial treatment
- Patient requires antibiotic therapy (purulent infection)
- Concern for outbreak or cluster
The evidence strongly supports starting with narrow-spectrum beta-lactams for uncomplicated nonpurulent skin tears, escalating only when clinical features warrant broader coverage. This approach balances effective treatment with antimicrobial stewardship.